Emergent Biosolutions reported $1.11B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Akebia Therapeutics AKBA:US $ 330.08M 0.99M
ALKERMES ALKS:US 1.05B 15.25M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amarin AMRN:US $ 963.03M 32.95M
Ani Pharmaceuticals ANIP:US $ 191.38M 415K
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Chimerix CMRX:US 128.53M 7.72M
Coherus Biosciences CHRS:US $ 673.04M 13.03M
Emergent Biosolutions EBS:US $ 1111.5M 50.6M
Exact Sciences EXAS:US $ 1615.59M 53.62M
Exelixis EXEL:US $ 1662.03M 68.78M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Glaxosmithkline GSK:US $ 18254M 688M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Immunogen IMGN:US $ 296.8M 22.41M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Ironwood Pharmaceuticals IRWD:US $ 695.37M 75.11M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Lonza Group LONN:SW 5.03B 229M
Moderna Inc MRNA:US 13.42B 2.46B
Myriad Genetics MYGN:US $ 498.9M 40M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Neurocrine Biosciences NBIX:US $ 1005.7M 104.4M
Opko Health OPK:US $ 557.51M 10.48M
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
United Therapeutics UTHR:US $ 2385.9M 68M
Vanda Pharmaceuticals VNDA:US $ 461.81M 15.16M
Xoma XOMA:US $ 74.87M 12.38M